Novavax Inc (NASDAQ:NVAX)
| 7.20 BATS BZX Real-Time Price As of 10:27am ET |  -0.015 / -0.21%Today’s Change | 5.61 Today|||52-Week Range 76.77 | -30.01% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $590.3M |
Company Description
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Contact Information
Novavax, Inc. 21 Firstfield Road Gaithersburg Maryland 20878 |
Employees
Shareholders
| Other institutional | 39.69% |
| Mutual fund holders | 30.16% |
| Individual stakeholders | 0.30% |
Top Executives
| John C.s Jacobs | President, Chief Executive Officer & Director |
| Richard Crowley | Chief Operating Officer & Executive Vice President |
| James Patrick Kelly | Chief Financial Officer, Treasurer & Executive VP |
| Gale E. Smith | Chief Scientist & Senior Vice President-Discovery |
| Biegie Lee | Chief Information Officer & Senior Vice President |
